Clinical Trials List
Protocol NumberWC45725
Not yet recruiting
2026-03-01 - 2030-12-31
Phase III
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Principal Investigator
周莒光
Co-Principal Investigator
- 蘇冠伃 Division of Endocrinology
- Chin-Sung Kuo Division of Endocrinology
- 吳崇暉 Division of Endocrinology
- 柯富翔 Division of Endocrinology
Co-Principal Investigator
- Hua-Shui Hsu Division of Family Medicine
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
240 participants
-
Global
2000 participants